| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 01/28/2015 | CN104321430A 新颖的抗-siglec-15抗体 Novel anti -siglec-15 antibody |
| 01/28/2015 | CN104321061A 施用依立托伦或其药学上可接受的盐以治疗正粘病毒感染 Administered in accordance with the legislation in Torun, or a pharmaceutically acceptable salt thereof to treat infections orthomyxovirus |
| 01/28/2015 | CN104312994A 调节性t细胞的亚磷蛋白及其应用 Regulatory protein and phosphorous application t cells |
| 01/28/2015 | CN104306993A 循环miR-505在高血压早期诊断及靶器官早期损伤预警作用中的应用 Circulating miR-505 used in the early diagnosis and early warning role of target organ damage in hypertension |
| 01/28/2015 | CN104306992A 循环miR-210在高血压早期诊断及靶器官损害预警中的应用 Circulating miR-210 in the early diagnosis of hypertension and target organ damage Early Warning |
| 01/28/2015 | CN104306980A 一种制备多尺度窄分布可生物降解微纳球的方法 A narrow distribution of multi-scale method biodegradable microspheres prepared nanospheres |
| 01/28/2015 | CN104306977A 治疗癌症的方法和组合物 Methods of treating cancer and compositions |
| 01/28/2015 | CN104306976A 一种高效的肿瘤个体化免疫治疗方法及其应用 An efficient individual tumor immunotherapy method and its application |
| 01/28/2015 | CN104306975A 固体药物组合物 Solid pharmaceutical composition |
| 01/28/2015 | CN104306974A 治疗造影剂诱导的肾病的方法 Method of treatment of contrast medium-induced nephropathy |
| 01/28/2015 | CN102458387B 用于治疗cmt及相关病症的新组合物 For the treatment of disorders associated cmt and new compositions |
| 01/27/2015 | US8940897 1,3,4-oxadiazole and 1,3,4-thiadiazole β-lactamase inhibitors |
| 01/27/2015 | US8940791 Acetylated amino acids as anti-platelet agents, nutritional and vitamin supplements |
| 01/27/2015 | US8940787 Use of artemisinin for treating tumors induced by oncogenic viruses and for treating viral infections |
| 01/27/2015 | US8940762 Methods for treating pain |
| 01/27/2015 | US8940760 Pyrazolo pyridine derivatives as NADPH oxidase inhibitors |
| 01/27/2015 | US8940755 Therapeutic combinations and methods including IRM compounds |
| 01/27/2015 | US8940751 Purine compounds as prodrugs of A2B adenosine receptor antagonists, their process and medicinal applications |
| 01/27/2015 | US8940737 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases |
| 01/27/2015 | US8940736 Imidazotriazinecarbonitriles useful as kinase inhibitors |
| 01/27/2015 | US8940735 Metalloenzyme inhibitor compounds |
| 01/27/2015 | US8940730 Methods and compositions of treating a Flaviviridae family viral infection |
| 01/27/2015 | US8940727 Benzazepine compound |
| 01/27/2015 | US8940723 Combination of a pyrroloquinoline compound and a beta-lactam antimicrobial agent, mupirocin or chlorhexidine |
| 01/27/2015 | US8940718 Antiviral compounds |
| 01/27/2015 | US8940713 Micro-RNA family that modulates fibrosis and uses thereof |
| 01/27/2015 | US8940712 Micro-RNA family that modulates fibrosis and uses thereof |
| 01/27/2015 | US8940711 Micro-RNA family that modulates fibrosis and uses thereof |
| 01/27/2015 | US8940701 Compounds for, and methods of, treating cancer and inhibiting invasion and metastases |
| 01/27/2015 | US8940695 Flt4 (VEGFR-3) as a target for tumor imaging and anti-tumor therapy |
| 01/27/2015 | US8940674 High alcohol content foaming compositions |
| 01/27/2015 | US8940319 Formulations, devices and methods for treating and preventing mucositis |
| 01/27/2015 | US8940300 Humanized antibodies targeting the EC1 domain of Cadherin-11 and related compositions and methods |
| 01/27/2015 | US8940291 Compositions and methods for enhancing virus efficacy |
| 01/27/2015 | US8940281 Composition using cross-linked hyaluronic acid for topical cosmetic and therapeutic applications |
| 01/27/2015 | US8940018 High strength suture with absorbable core and suture anchor combination |
| 01/27/2015 | CA2480311C Oligomeric compounds for the modulation of hif-1alpha expression |
| 01/27/2015 | CA2470104C Methods for using extracellular adenosine inhibitors and adenosine receptor inhibitors to enhance immune response and inflammation |
| 01/22/2015 | WO2015009591A2 Treatment for melanoma |
| 01/22/2015 | WO2015009533A1 Gabaa receptor antagonists affecting ganglion cell function and visual function |
| 01/22/2015 | WO2015007869A1 Local anesthetics and use thereof in cancer |
| 01/22/2015 | WO2015007552A1 Ophthalmic compositions containing a nitric oxide donor |
| 01/22/2015 | US20150025511 Pharmaceutical compositions for intraocular administration and methods for fabricating thereof |
| 01/22/2015 | US20150025480 Composition for the transdermal delivery of fentanyl |
| 01/22/2015 | US20150025108 8-hydroxy quinoline derivatives |
| 01/22/2015 | US20150025101 Opioid agonist/antagonist combinations |
| 01/22/2015 | US20150025090 Substituted azabicycles and use thereof |
| 01/22/2015 | US20150025081 Novel phenylimidazole derivatives as pde10a enzyme inhibitors |
| 01/22/2015 | US20150025072 Quinazolinone compounds |
| 01/22/2015 | US20150025065 New azabenzimidazole derivatives |
| 01/22/2015 | US20150025064 Novel benzodiazepinones as modulators of metabotropic glutamate receptor functions and neurological uses thereof |
| 01/22/2015 | US20150025063 Antiparkinsonian Action of Phenylisopropylamines |
| 01/22/2015 | US20150025057 Triazine-oxadiazoles |
| 01/22/2015 | US20150025048 Methods for enhancing, improving, or increasing fertility or reproductive function |
| 01/22/2015 | US20150025046 Preparation and use of bicyclic himbacine derivatives as par-1 receptor antagonists |
| 01/22/2015 | US20150025045 CBP AND p300-MEDIATED TRANSCRIPTION MODULATORS AND RELATED METHODS |
| 01/22/2015 | US20150025041 Antiviral therapies with phospholipase d inhibitors |
| 01/22/2015 | US20150025028 Method for Treating Abnormal Polyglutamine-Mediated Disease |
| 01/22/2015 | US20150025023 Cyclodextrin |
| 01/22/2015 | US20150025022 Novel il-17r-ecd mutants |
| 01/22/2015 | US20150025017 Compositions and methods for treating cancer |
| 01/22/2015 | US20150025002 Peptides and peptide derivatives based on xenin |
| 01/22/2015 | US20150025000 Methods for Treating HCV |
| 01/22/2015 | US20150024996 Pharmaceutical compositions for intraocular administration and methods for fabricating thereof |
| 01/22/2015 | US20150024994 Use of thymosin alpha for the treatment of sepsis |
| 01/22/2015 | US20150024076 Methods and compositions for enhancing hair quality using blackberry extract |
| 01/22/2015 | US20150024071 Inhibitors of catechol o-methyl transferase and their use in the treatment of psychotic disorders |
| 01/22/2015 | US20150024065 Treatment of retroviral reservoirs exploiting oxidative stress |
| 01/22/2015 | US20150024053 Topical wound treatment method and composition |
| 01/22/2015 | US20150024010 Methods of therapeutic treatment of eyes |
| 01/22/2015 | US20150023997 Compositions, methods and therapies for administering antigen peptide |
| 01/22/2015 | US20150023976 Antibody polypeptides that antagonize cd40l |
| 01/22/2015 | US20150023964 FcgammaRIIB-Specific Antibodies and Methods of Use Thereof |
| 01/22/2015 | US20150023955 Treatment and Diagnosis of Melanoma |
| 01/22/2015 | US20150023930 Aminoquinoline derivatives and uses thereof |
| 01/22/2015 | US20150023920 Novel compositions and methods for preventing or treating cancer metastasis |
| 01/22/2015 | US20150023917 Treatment for infection with hepatitis b virus alone or in combination with hepatitis delta virus and associated liver diseases |
| 01/22/2015 | US20150023916 Antiviral drugs for treatment of arenavirus infection |
| 01/22/2015 | US20150023915 Treatment for melanoma |
| 01/22/2015 | US20150023914 Use of tellurium compounds for the treatment actinic keratosis |
| 01/22/2015 | US20150023913 Hepatitis C Virus Inhibitors |
| 01/22/2015 | US20150023910 Granulysin in immunotherapy |
| 01/22/2015 | US20150023907 Reactivation of hiv-1 gene expression to treat persistent hiv infection |
| 01/22/2015 | US20150023905 Synthetic mechanical hemostatic composition, method of making and use thereof |
| 01/22/2015 | US20150023895 UV Compositions Having Low Active Concentrations and High In Vivo SPF |
| 01/22/2015 | US20150023893 Method of improving the appearance of aging skin |
| 01/22/2015 | US20150023889 Fluoride-responsive riboswitchs, fluoride transporters, and methods of use |
| 01/22/2015 | US20150023868 Hif inhibitors and use thereof |
| 01/22/2015 | DE69831673C5 Verwendung von exedinen und deren antagonisten zur verminderung der lebensmittelaufnahme Use of exedinen and their antagonists to rundown the food intake |
| 01/21/2015 | EP2826770A1 Acylguanidine compounds with antiviral activity |
| 01/21/2015 | EP2826491A1 Ophthalmic compositions containing a nitric oxide donor |
| 01/21/2015 | EP2826480A1 Combinations for the treatment of diseases involving cell proliferation, migration or apoptosis of myeloma cells, or angiogenesis |
| 01/21/2015 | EP2826478A1 Combinations comprising mglur modulators for the treatment of parkinson's disease |
| 01/21/2015 | EP2825187A1 Combination of a mc1r receptor agonist and uvb for the treatment and/or prevention of pigmentation disorders |
| 01/21/2015 | EP2825162A1 Compounds and methods for treating leukemia |
| 01/21/2015 | CN104302322A 骨·软组织中产生的巨细胞性肿瘤或软骨肉瘤的预防或治疗剂 Bone-soft tissue produced in giant cell tumor or chondrosarcoma prophylactic or therapeutic agent |
| 01/21/2015 | CN104302297A 用于治疗皮肤疾病的寡糖组合物 For the treatment of skin diseases oligosaccharide composition |
| 01/21/2015 | CN104302290A 丙型肝炎病毒抑制剂 Hepatitis C virus inhibitors |
| 01/21/2015 | CN104302288A 包含(1r,4r)-6'-氟-N,N-二甲基-4-苯基-4',9'-二氢-3'H-螺[环己烷-1,1'-吡喃并-[3,4,b]吲哚]-4-胺和昔康类的药物组合物 Comprising (1r, 4r) -6'- fluoro -N, N- dimethyl-4-phenyl-4 ', 9'-dihydro -3'H- spiro [cyclohexane-1,1'-pyrazol furans and - [3,4, b] indole] -4-amine and pharmaceutical compositions of meloxicam |
| 01/21/2015 | CN104302282A 包含(1r,4r)-6'-氟-N,N-二甲基-4-苯基-4',9'-二氢-3'H-螺[环己烷-1,1'-吡喃并-[3,4,b]吲哚]-4-胺和对乙酰氨基酚或丙帕他莫的药物组合物 Comprising (1r, 4r) -6'- fluoro -N, N- dimethyl-4-phenyl-4 ', 9'-dihydro -3'H- spiro [cyclohexane-1,1'-pyrazol furans and - [3,4, b] indole] -4-amine and acetaminophen or Propacetamol pharmaceutical compositions |